Our ambition
Ensuring transparency in our supply chain by fostering strong relationships with suppliers, upholding corporate governance, and practicing responsible business management.
We aim to strengthen the close relationships we share with our global supplier network by continuously enhancing our ethical standards, fostering trust, transparency, and promoting responsible business practices.
Our target
- Supplier Guidelines for Responsible Growth: Seek Board of Directors approval and publish approved version of the guidelines for suppliers across ICE Pharma by end of Q2 2025.
- Seek associate membership to the Pharmaceutical Supply Chain Initiative (PSCI) in 2025, with view to obtain full membership in 2026.
